Autonomic modulation and health-related quality of life among schizophrenic patients treated with non-intensive case management

Li Ren Chang, Yu Hsuan Lin, Terry B J Kuo, Hung Chieh Wu Chang, Chih Min Liu, Chen Chung Liu, Hai Gwo Hwu, Cheryl C H Yang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Schizophrenia is associated with autonomic dysfunction and this may increase cardiovascular mortality. Past studies on autonomic modulation of schizophrenic patients focused on inpatients rather than individuals in a community setting, especially those receiving non-intensive case management (non-ICM). Besides, autonomic modulation and its association with health-related quality of life (HRQoL) in this population remain unexplored. Methods: A total of 25 schizophrenic patients treated by non-ICM and 40 healthy volunteers were matched by age, gender and body mass index; smokers were excluded. Between the two groups, we compared the individuals' 5 min resting assessments of heart rate variability and their HRQoL, which was measured using EuroQoL-5D (EQ-5D). Patients with schizophrenia were assessed for psychopathology using the Positive and Negative Syndrome Scale for Schizophrenia (PANSS). We examined the relationship between heart rate variability measurements, HRQoL scores, PANSS scores, and other clinical variables among the schizophrenic patients treated by non-ICM. Results: Compared to the controls, patients with schizophrenia showed a significant impairment of autonomic modulation and a worse HRQoL. Cardiovagal dysfunction among the schizophrenic patients could be predicted independently based on lower educational level and more negative symptoms. Sympathetic predominance was directly associated with anticholinergics use and EQ-5D using a visual analogue scale (EQ-VAS). Conclusion: Patients with schizophrenia treated by non-ICM show a significant impairment of their autonomic function and HRQoL compared to the controls. Since the sympathovagal dysfunction is associated with more negative symptoms or higher VAS score, the treatment of the negative symptoms as well as the monitoring of HRQoL might help to manage cardiovascular risk among these individuals. In addition, EQ-VAS scores must be interpreted more cautiously in such a population.

Original languageEnglish
Article numbere26378
JournalPLoS One
Volume6
Issue number11
DOIs
Publication statusPublished - Nov 4 2011
Externally publishedYes

Fingerprint

Case Management
quality of life
Quality of Life
Modulation
Health
Schizophrenia
signs and symptoms (animals and humans)
Visual Analog Scale
Heart Rate
heart rate
Cholinergic Antagonists
Psychopathology
educational status
Population
Inpatients
Healthy Volunteers
Body Mass Index
volunteers
body mass index
schizophrenia

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Autonomic modulation and health-related quality of life among schizophrenic patients treated with non-intensive case management. / Chang, Li Ren; Lin, Yu Hsuan; Kuo, Terry B J; Chang, Hung Chieh Wu; Liu, Chih Min; Liu, Chen Chung; Hwu, Hai Gwo; Yang, Cheryl C H.

In: PLoS One, Vol. 6, No. 11, e26378, 04.11.2011.

Research output: Contribution to journalArticle

Chang, Li Ren ; Lin, Yu Hsuan ; Kuo, Terry B J ; Chang, Hung Chieh Wu ; Liu, Chih Min ; Liu, Chen Chung ; Hwu, Hai Gwo ; Yang, Cheryl C H. / Autonomic modulation and health-related quality of life among schizophrenic patients treated with non-intensive case management. In: PLoS One. 2011 ; Vol. 6, No. 11.
@article{1514a6a027b7486fb8129807e62222d0,
title = "Autonomic modulation and health-related quality of life among schizophrenic patients treated with non-intensive case management",
abstract = "Background: Schizophrenia is associated with autonomic dysfunction and this may increase cardiovascular mortality. Past studies on autonomic modulation of schizophrenic patients focused on inpatients rather than individuals in a community setting, especially those receiving non-intensive case management (non-ICM). Besides, autonomic modulation and its association with health-related quality of life (HRQoL) in this population remain unexplored. Methods: A total of 25 schizophrenic patients treated by non-ICM and 40 healthy volunteers were matched by age, gender and body mass index; smokers were excluded. Between the two groups, we compared the individuals' 5 min resting assessments of heart rate variability and their HRQoL, which was measured using EuroQoL-5D (EQ-5D). Patients with schizophrenia were assessed for psychopathology using the Positive and Negative Syndrome Scale for Schizophrenia (PANSS). We examined the relationship between heart rate variability measurements, HRQoL scores, PANSS scores, and other clinical variables among the schizophrenic patients treated by non-ICM. Results: Compared to the controls, patients with schizophrenia showed a significant impairment of autonomic modulation and a worse HRQoL. Cardiovagal dysfunction among the schizophrenic patients could be predicted independently based on lower educational level and more negative symptoms. Sympathetic predominance was directly associated with anticholinergics use and EQ-5D using a visual analogue scale (EQ-VAS). Conclusion: Patients with schizophrenia treated by non-ICM show a significant impairment of their autonomic function and HRQoL compared to the controls. Since the sympathovagal dysfunction is associated with more negative symptoms or higher VAS score, the treatment of the negative symptoms as well as the monitoring of HRQoL might help to manage cardiovascular risk among these individuals. In addition, EQ-VAS scores must be interpreted more cautiously in such a population.",
author = "Chang, {Li Ren} and Lin, {Yu Hsuan} and Kuo, {Terry B J} and Chang, {Hung Chieh Wu} and Liu, {Chih Min} and Liu, {Chen Chung} and Hwu, {Hai Gwo} and Yang, {Cheryl C H}",
year = "2011",
month = "11",
day = "4",
doi = "10.1371/journal.pone.0026378",
language = "English",
volume = "6",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Autonomic modulation and health-related quality of life among schizophrenic patients treated with non-intensive case management

AU - Chang, Li Ren

AU - Lin, Yu Hsuan

AU - Kuo, Terry B J

AU - Chang, Hung Chieh Wu

AU - Liu, Chih Min

AU - Liu, Chen Chung

AU - Hwu, Hai Gwo

AU - Yang, Cheryl C H

PY - 2011/11/4

Y1 - 2011/11/4

N2 - Background: Schizophrenia is associated with autonomic dysfunction and this may increase cardiovascular mortality. Past studies on autonomic modulation of schizophrenic patients focused on inpatients rather than individuals in a community setting, especially those receiving non-intensive case management (non-ICM). Besides, autonomic modulation and its association with health-related quality of life (HRQoL) in this population remain unexplored. Methods: A total of 25 schizophrenic patients treated by non-ICM and 40 healthy volunteers were matched by age, gender and body mass index; smokers were excluded. Between the two groups, we compared the individuals' 5 min resting assessments of heart rate variability and their HRQoL, which was measured using EuroQoL-5D (EQ-5D). Patients with schizophrenia were assessed for psychopathology using the Positive and Negative Syndrome Scale for Schizophrenia (PANSS). We examined the relationship between heart rate variability measurements, HRQoL scores, PANSS scores, and other clinical variables among the schizophrenic patients treated by non-ICM. Results: Compared to the controls, patients with schizophrenia showed a significant impairment of autonomic modulation and a worse HRQoL. Cardiovagal dysfunction among the schizophrenic patients could be predicted independently based on lower educational level and more negative symptoms. Sympathetic predominance was directly associated with anticholinergics use and EQ-5D using a visual analogue scale (EQ-VAS). Conclusion: Patients with schizophrenia treated by non-ICM show a significant impairment of their autonomic function and HRQoL compared to the controls. Since the sympathovagal dysfunction is associated with more negative symptoms or higher VAS score, the treatment of the negative symptoms as well as the monitoring of HRQoL might help to manage cardiovascular risk among these individuals. In addition, EQ-VAS scores must be interpreted more cautiously in such a population.

AB - Background: Schizophrenia is associated with autonomic dysfunction and this may increase cardiovascular mortality. Past studies on autonomic modulation of schizophrenic patients focused on inpatients rather than individuals in a community setting, especially those receiving non-intensive case management (non-ICM). Besides, autonomic modulation and its association with health-related quality of life (HRQoL) in this population remain unexplored. Methods: A total of 25 schizophrenic patients treated by non-ICM and 40 healthy volunteers were matched by age, gender and body mass index; smokers were excluded. Between the two groups, we compared the individuals' 5 min resting assessments of heart rate variability and their HRQoL, which was measured using EuroQoL-5D (EQ-5D). Patients with schizophrenia were assessed for psychopathology using the Positive and Negative Syndrome Scale for Schizophrenia (PANSS). We examined the relationship between heart rate variability measurements, HRQoL scores, PANSS scores, and other clinical variables among the schizophrenic patients treated by non-ICM. Results: Compared to the controls, patients with schizophrenia showed a significant impairment of autonomic modulation and a worse HRQoL. Cardiovagal dysfunction among the schizophrenic patients could be predicted independently based on lower educational level and more negative symptoms. Sympathetic predominance was directly associated with anticholinergics use and EQ-5D using a visual analogue scale (EQ-VAS). Conclusion: Patients with schizophrenia treated by non-ICM show a significant impairment of their autonomic function and HRQoL compared to the controls. Since the sympathovagal dysfunction is associated with more negative symptoms or higher VAS score, the treatment of the negative symptoms as well as the monitoring of HRQoL might help to manage cardiovascular risk among these individuals. In addition, EQ-VAS scores must be interpreted more cautiously in such a population.

UR - http://www.scopus.com/inward/record.url?scp=80455149781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80455149781&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0026378

DO - 10.1371/journal.pone.0026378

M3 - Article

C2 - 22073161

AN - SCOPUS:80455149781

VL - 6

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 11

M1 - e26378

ER -